135 related articles for article (PubMed ID: 34623186)
21. Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction.
Suk KT; Kim HS; Kim JW; Baik SK; Kwon SO; Kim HG; Lee DH; Yoo BM; Kim JH; Moon YS; Lee DK
Gastrointest Endosc; 2006 Oct; 64(4):522-9. PubMed ID: 16996343
[TBL] [Abstract][Full Text] [Related]
22. Role of percutaneous cholecystostomy for acute acalculous cholecystitis: clinical outcomes of 271 patients.
Noh SY; Gwon DI; Ko GY; Yoon HK; Sung KB
Eur Radiol; 2018 Apr; 28(4):1449-1455. PubMed ID: 29116391
[TBL] [Abstract][Full Text] [Related]
23. Placement of a Newly Designed Y-Configured Bilateral Self-Expanding Metallic Stent for Hilar Biliary Obstruction: A Pilot Study.
Jiao D; Huang K; Zhu M; Wu G; Ren J; Wang Y; Han X
Dig Dis Sci; 2017 Jan; 62(1):253-263. PubMed ID: 27586033
[TBL] [Abstract][Full Text] [Related]
24. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study.
Suk KT; Kim JW; Kim HS; Baik SK; Oh SJ; Lee SJ; Kim HG; Lee DH; Won YH; Lee DK
Gastrointest Endosc; 2007 Oct; 66(4):798-803. PubMed ID: 17905025
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of compound tri-metal stent placement for malignant perihilar biliary obstruction.
Kim KM; Jeong CU; Shim SG; Jang H; Song YG; Kim TG; Ji JH
Niger J Clin Pract; 2018 Sep; 21(9):1121-1126. PubMed ID: 30156195
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous transcholecystic metallic stent placement for malignant obstruction of the common bile duct: preliminary clinical evaluation.
Yasumoto T; Yokoyama S; Nagaike K
J Vasc Interv Radiol; 2010 Feb; 21(2):252-8. PubMed ID: 20123209
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous placement of metallic stents in the management of malignant biliary obstruction.
Chiou YY; Tseng HS; Chiang JH; Hwang JI; Chou YH; Chang CY
J Formos Med Assoc; 2005 Oct; 104(10):738-43. PubMed ID: 16385376
[TBL] [Abstract][Full Text] [Related]
28. Self-expandable metallic stents for malignant biliary obstruction with an anomalous pancreaticobiliary junction.
Kogure H; Tsujino T; Yagioka H; Sasaki T; Nakai Y; Hirano K; Sasahira N; Isayama H; Tada M; Kawabe T; Omata M
Surg Endosc; 2008 Mar; 22(3):787-91. PubMed ID: 17704880
[TBL] [Abstract][Full Text] [Related]
29. Similar performance but higher cholecystitis rate with covered biliary stents: results from a prospective multicenter evaluation.
Fumex F; Coumaros D; Napoleon B; Barthet M; Laugier R; Yzet T; Le Sidaner A; Desurmont P; Lamouliatte H; Letard JC; Canard JM; Prat F; Rey JF; Ponchon T;
Endoscopy; 2006 Aug; 38(8):787-92. PubMed ID: 17001568
[TBL] [Abstract][Full Text] [Related]
30. Partially Covered Metal Stents May Not Prolong Stent Patency Compared to Uncovered Stents in Unresectable Malignant Distal Biliary Obstruction.
Kim JY; Ko GB; Lee TH; Park SH; Lee YN; Cho YS; Jung Y; Chung IK; Choi HJ; Cha SW; Moon JH; Cho YD; Kim SJ
Gut Liver; 2017 May; 11(3):440-446. PubMed ID: 28208003
[TBL] [Abstract][Full Text] [Related]
31. The safety and efficacy of percutaneous intraductal radiofrequency ablation in unresectable malignant biliary obstruction: A single-institution experience.
Cui W; Fan W; Lu M; Zhang Y; Yao W; Li J; Wang Y
BMC Cancer; 2017 Apr; 17(1):288. PubMed ID: 28438130
[TBL] [Abstract][Full Text] [Related]
32. Identification of risk factors for obstructive cholecystitis following placement of biliary stent in unresectable malignant biliary obstruction: a 5-year retrospective analysis in single center.
Jung JH; Park SW; Hyun B; Lee J; Koh DH; Chung D
Surg Endosc; 2021 Jun; 35(6):2679-2689. PubMed ID: 32556765
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of Percutaneous Cholecystostomy for Acute Cholecystitis.
Pang KW; Tan CH; Loh S; Chang KY; Iyer SG; Madhavan K; Kow WC
World J Surg; 2016 Nov; 40(11):2735-2744. PubMed ID: 27255942
[TBL] [Abstract][Full Text] [Related]
34. A prospective, multicenter study of a double stent system for palliative treatment of malignant extrahepatic biliary obstructions.
Kim JW; Gwon D; Han YM; Won JH; Hong HP; Ko GY; Yoon HK; Sung KB
Acta Radiol; 2015 Oct; 56(10):1209-15. PubMed ID: 25260418
[TBL] [Abstract][Full Text] [Related]
35. Management of occluded self-expanding biliary metal stents in malignant biliary disease.
Nennstiel S; Tschurtschenthaler I; Neu B; Algül H; Bajbouj M; Schmid RM; von Delius S; Weber A
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):49-54. PubMed ID: 29428104
[TBL] [Abstract][Full Text] [Related]
36. Early infectious complications of percutaneous metallic stent insertion for malignant biliary obstruction.
Li Sol Y; Kim CW; Jeon UB; Lee NK; Kim S; Kang DH; Kim GH
AJR Am J Roentgenol; 2010 Jan; 194(1):261-5. PubMed ID: 20028931
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous bilateral metallic stent placement using a stentin-stent deployment technique in patients with malignant hilar biliary obstruction.
Gwon DI; Ko GY; Kim JH; Shin JH; Kim KA; Yoon HK; Sung KB
AJR Am J Roentgenol; 2013 Apr; 200(4):909-14. PubMed ID: 23521469
[TBL] [Abstract][Full Text] [Related]
38. Folfirinox chemotherapy prolongs stent patency in patients with malignant biliary obstruction due to unresectable pancreatic cancer.
Kang J; Lee SH; Choi JH; Paik WH; Ahn DW; Jeong JB; Ryu JK; Kim YT
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):590-595. PubMed ID: 32532598
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous cholecystostomy in the management of high-risk patients presenting with acute cholecystitis: Timing and outcome at a single institution.
Zarour S; Imam A; Kouniavsky G; Lin G; Zbar A; Mavor E
Am J Surg; 2017 Sep; 214(3):456-461. PubMed ID: 28237047
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous intraductal radiofrequency ablation for clearance of occluded metal stent in malignant biliary obstruction: feasibility and early results.
Pai M; Valek V; Tomas A; Doros A; Quaretti P; Golfieri R; Mosconi C; Habib N
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):235-40. PubMed ID: 23842684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
